发明名称 Anti-Viral Compounds
摘要 Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
申请公布号 US2012220562(A1) 申请公布日期 2012.08.30
申请号 US201213404429 申请日期 2012.02.24
申请人 DEGOEY DAVID A;KATI WARREN M.;HUTCHINS CHARLES W.;DONNER PAMELA L.;KRUEGER ALLAN C.;RANDOLPH JOHN T.;PATEL SACHIN V.;MATULENKO MARK A.;KEDDY RYAN G.;JINKERSON TAMMIE K.;GAO YI;LIU DACHUN;PRATT JOHN K.;ROCKWAY TODD W.;MARING CLARENCE J.;HUTCHINSON DOUGLAS K.;FLENTGE CHARLES A.;WAGNER ROLF;BETEBENNER DAVID A.;SARRIS KATHY;WOLLER KEVIN R.;CARROLL WILLIAM A.;ABBOTT LABAORATORIES 发明人 DEGOEY DAVID A;KATI WARREN M.;HUTCHINS CHARLES W.;DONNER PAMELA L.;KRUEGER ALLAN C.;RANDOLPH JOHN T.;PATEL SACHIN V.;MATULENKO MARK A.;KEDDY RYAN G.;JINKERSON TAMMIE K.;GAO YI;LIU DACHUN;PRATT JOHN K.;ROCKWAY TODD W.;MARING CLARENCE J.;HUTCHINSON DOUGLAS K.;FLENTGE CHARLES A.;WAGNER ROLF;BETEBENNER DAVID A.;SARRIS KATHY;WOLLER KEVIN R.;CARROLL WILLIAM A.
分类号 A61K31/496;A61K31/4178;A61K31/454;A61K31/4545;A61K31/506;A61P31/14;C07D401/14;C07D403/14;C07D405/14 主分类号 A61K31/496
代理机构 代理人
主权项
地址